On July 10, 2025, the U.S. Food and Drug Administration (FDA) announced that it was embracing “radical transparency” by publishing more than 200 Complete Response Letters (CRLs) — letters the agency ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results